“A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom,” Stat reports.
“The nature of the adverse reaction and when it happened was not immediately known, though the participant is expected to recover.”